Filing Details
- Accession Number:
- 0001209191-23-018042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-10 21:00:15
- Reporting Period:
- 2023-03-09
- Accepted Time:
- 2023-03-10 21:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1630627 | Treace Medical Concepts Inc. | TMCI | Surgical & Medical Instruments & Apparatus (3841) | 471052611 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856371 | F. Sean Scanlan | C/O Treace Medical Concepts, Inc. 100 Palmetto Park Place Ponte Vedra FL 32081 | Chief Innovation Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-09 | 505 | $24.41 | 9,470 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-10 | 22,925 | $0.00 | 32,395 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy) | Stock Option (Right to Buy) | Disposition | 2023-03-10 | 51,950 | $0.00 | 51,950 | $24.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 51,950 | 2033-03-10 | No | 4 | A | Direct |
Footnotes
- The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with thevesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does notrepresent a discretionary transaction by the Reporting Person.
- Includes 8,331 RSUs.
- Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for eachRSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
- Includes 31,256 RSUs.
- The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027;subject to Reporting Person's providing continued service to Issuer through each vesting date.
Billionaire Hedge Funds
